| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/06/2008 | EP1951674A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 08/06/2008 | EP1951667A2 Thrombopoietin activity modulating compounds and methods |
| 08/06/2008 | EP1951665A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 08/06/2008 | EP1951254A2 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| 08/06/2008 | EP1907366A4 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1638943B1 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 08/06/2008 | EP1532113B1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 08/06/2008 | EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 08/06/2008 | CN101238106A Fluoro substituted 2-oxo azepan derivatives |
| 08/06/2008 | CN101235032A Compound and preparation method thereof |
| 08/06/2008 | CN100408574C Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408570C EP4 receptor antagonists |
| 08/06/2008 | CN100408565C Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 08/05/2008 | US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma |
| 08/05/2008 | US7407946 Quinazoline compounds |
| 08/05/2008 | CA2180074C Process for the preparation of 3-hydroxyoxetanes |
| 07/31/2008 | WO2008091818A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | WO2008091580A2 Fungicidal amides |
| 07/31/2008 | WO2008090757A1 Squarylium compound, squarylium compound-containing composition, optical filter and front filter for display |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008062424A3 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2007077201A9 Piperazine compounds with a herbicidal action |
| 07/31/2008 | US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine |
| 07/31/2008 | US20080182889 Prodrugs of excitatory amino acids |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182878 benzothienyl containing amido-derivatives, antibacterial agent; quorum sensing regulated virulence factors; inhibiting biofilm formation; virulence gene expression blocking agent, disinfectants, antifouling coatings |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182859 Small organic molecule regulators of cell proliferation |
| 07/31/2008 | US20080182854 4-Amino-5-Cyanopyrimidine Derivatives |
| 07/31/2008 | US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/31/2008 | DE4345590B4 Selbstlade-Granatwerfer Self-loading grenade launcher |
| 07/31/2008 | CA2676252A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1948647A1 Pyrimidinyl-thiophene kinase modulators |
| 07/30/2008 | EP1948633A2 3 -hydroxyflavone derivatives for the detection and the quantification of cell apoptosis |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1747204B1 Tri-substituted ureas as cytokine inhibitors |
| 07/30/2008 | EP1685113B1 Substituted pyrazoles as ppar agonists |
| 07/30/2008 | EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 07/30/2008 | EP1606267B1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 07/30/2008 | EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors |
| 07/30/2008 | EP1542973B1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 07/30/2008 | CN101233132A Compounds for modulating TRPV3 function |
| 07/30/2008 | CN101233128A Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 07/30/2008 | CN101233127A Heterocyclic compound and organic electroluminescent device using same |
| 07/30/2008 | CN101233114A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors |
| 07/30/2008 | CN101233113A Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation |
| 07/30/2008 | CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders |
| 07/30/2008 | CN101230264A Solution-processable phosphorescent materials |
| 07/30/2008 | CN101230263A Solution-processable phosphorescent materials |
| 07/30/2008 | CN101230038A Pyridine carboxamide derivatives and their use as pesticides |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406442C 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405308 polymerization catalysts such as 5-(2,4-dimethylphenyl) thianthrenium hexafluoroantimonate, used for polymerization of epoxy and vinyl ether monomers |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/24/2008 | WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | WO2008087514A2 Hdac inhibitors |
| 07/24/2008 | WO2008086729A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008059339A3 Isoquinoline derivatives as vanilloid receptor modulators |
| 07/24/2008 | WO2008051406A3 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 07/24/2008 | WO2008049047A3 Quinoline compounds |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | WO2007080401A8 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/24/2008 | US20080177094 reducing an alkyl 2,4,9-trithiaadamantane-7-carboxylate to produce 7-hydroxymethyl-2,4,9-trithiaadamantane; andoxidizing 7-hydroxymethyl-2,4,9-trithiaadamantane to produce 7-carbonyl-2,4,9-trithiaadamantane; Molecular wires having 2,4,9-trithiaadamantane surface anchors |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080176938 Modulation of pathogenicity |
| 07/24/2008 | US20080176903 Novel Compounds with Analgesic Effect |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176896 Modulators of cellular adhesion |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176848 e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders |